Vivozon Pharmaceutical Co Ltd
KOSDAQ:082800
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/FCFE
Price to Free Cash Flow to Equity (P/FCFE) ratio compares a company`s market value to the free cash flow available to its shareholders. It`s similar to the P/OCF ratio but more precise, since it accounts for capital expenditures deducted from operating cash flow.
Price to Free Cash Flow to Equity (P/FCFE) ratio compares a company`s market value to the free cash flow available to its shareholders. It`s similar to the P/OCF ratio but more precise, since it accounts for capital expenditures deducted from operating cash flow.
Valuation Scenarios
If P/FCFE returns to its Industry Average (28.9), the stock would be worth ₩-3 263.72 (201% downside from current price).
| Scenario | P/FCFE Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | -28.6 | ₩3 230 |
0%
|
| Industry Average | 28.9 | ₩-3 263.72 |
-201%
|
| Country Average | 15.1 | ₩-1 702.01 |
-153%
|
Forward P/FCFE
Today’s price vs future free cash flow to equity
Peer Comparison
| Market Cap | P/FCFE | P/E | ||||
|---|---|---|---|---|---|---|
| KR |
V
|
Vivozon Pharmaceutical Co Ltd
KOSDAQ:082800
|
196.1B KRW | -28.6 | -6.9 | |
| US |
|
NVIDIA Corp
NASDAQ:NVDA
|
4.8T USD | 60.7 | 40.2 | |
| US |
|
Broadcom Inc
NASDAQ:AVGO
|
2T USD | 78.3 | 79.9 | |
| TW |
|
Taiwan Semiconductor Manufacturing Co Ltd
TWSE:2330
|
55.4T TWD | 53.2 | 29.3 | |
| US |
|
Micron Technology Inc
NASDAQ:MU
|
611.6B USD | 113.1 | 25.4 | |
| US |
|
Advanced Micro Devices Inc
NASDAQ:AMD
|
587.7B USD | 103.3 | 135.6 | |
| KR |
|
SK Hynix Inc
KRX:000660
|
701.7T KRW | 28.6 | 16.1 | |
| US |
|
Intel Corp
NASDAQ:INTC
|
500.4B USD | -59.8 | -157.7 | |
| US |
|
Texas Instruments Inc
NASDAQ:TXN
|
254.9B USD | 51.8 | 47.8 | |
| UK |
|
Arm Holdings PLC
NASDAQ:ARM
|
224.3B USD | 233.9 | 280 | |
| US |
|
Analog Devices Inc
NASDAQ:ADI
|
194.2B USD | 34.4 | 71.7 |
Market Distribution
| Min | 0.2 |
| 30th Percentile | 8.1 |
| Median | 15.1 |
| 70th Percentile | 28.4 |
| Max | 21 200 |
Other Multiples
Vivozon Pharmaceutical Co Ltd
Glance View
Vivozon Pharmaceutical Co., Ltd. engages in the manufacture and sale of compound semiconductors. The company is headquartered in Yongin, Gyeonggi-Do. The company went IPO on 2005-11-18. The firm operates its business through three segments. The Pharmaceutical Business segment is engaged in the manufacture and sale of finished medicines such as external skin preparations, antipyretic analgesic, anti-inflammatory drugs and antidiabetic drugs. The Optical Business segment is engaged in the manufacture and sale of finished products and lighting module sets such as general lighting and automotive lighting using light emitting diode (LED) light sources. The Cosmetics Business segment is engaged in the manufacture and sale of cosmetics and cosmetic ingredients.
